RUNX3 and neoplasm: Among the genes that showed a trend toward hypermethylation in the pan-negative cases were RUNX3, a known tumor suppressor gene, and CCNA144, which has been reported to correlate with treatment response to doxorubicin and 5-fluorouracil (Fig. 6c, d).